Furthermore, magnesium supplementation exerts favorable effects on endothelial function in individuals at risk for diabetes [47, 48], suggesting another possible mechanism through which SGLT2 inhibitors achieve vascular protection. Here, SLC5A2 is linked to diabetes mellitus.